Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
Oncodesign, a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio a company specializing in R&D for rare diseases, have…
Read More...
Read More...